Eden Research (LON:EDEN) Trading Up 31% – Should You Buy?

Eden Research plc (LON:EDEN)’s stock price was up 31% during trading on Wednesday . The stock traded as high as GBX 4.39 ($0.06) and last traded at GBX 4.39 ($0.06). Approximately 1,139,355 shares traded hands during mid-day trading, an increase of 69% from the average daily volume of 675,899 shares. The stock had previously closed at GBX 3.35 ($0.04).

Eden Research Stock Up 2.6%

The company has a quick ratio of 2.42, a current ratio of 3.80 and a debt-to-equity ratio of 1.26. The company has a market cap of £21.33 million, a PE ratio of -14.01 and a beta of 0.92. The business has a 50-day simple moving average of GBX 2.82 and a 200-day simple moving average of GBX 3.44.

Eden Research (LON:EDEN) last posted its quarterly earnings results on Tuesday, May 6th. The company reported GBX (0.36) ($0.00) earnings per share for the quarter. Eden Research had a negative net margin of 38.70% and a negative return on equity of 11.63%. Equities research analysts anticipate that Eden Research plc will post -66.0000038 EPS for the current year.

Insiders Place Their Bets

In other news, insider Alexander John Abrey bought 167,947 shares of the firm’s stock in a transaction that occurred on Tuesday, March 4th. The stock was purchased at an average cost of GBX 3 ($0.04) per share, with a total value of £5,038.41 ($6,705.36). Also, insider Sean M. Smith bought 426,986 shares of the business’s stock in a transaction dated Tuesday, April 1st. The stock was acquired at an average cost of GBX 234 ($3.11) per share, for a total transaction of £999,147.24 ($1,329,714.19). Insiders own 14.02% of the company’s stock.

About Eden Research

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.